The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed CVA and potential Reverse Takeover

30 Jul 2020 12:25

RNS Number : 6429U
Ashley House PLC
30 July 2020
 

Ashley House plc

 

Proposed Company Voluntary Arrangement and potential Reverse Takeover

 

Ashley House plc ("Ashley House" or the "Company") announces that it has filed a Company Voluntary Arrangement ("CVA") proposal and is in discussions for the Company to potentially combine with Piper Homes plc ("Piper"), an unlisted Midland based housing developer, by way of a Reverse Takeover or similar transaction.

Background

On 6 March 2020, the Company announced that, due to the material uncertainty of the Company's current financial condition, trading in the Company's shares on both AIM and NEX was suspended from that date. Trading in the Company's shares on NEX was withdrawn on 26 March 2020.

Since that date, the Company has explored many options to raise further funding and corporate opportunities to meet its ongoing working capital commitments and to support its affordable housing strategy. This included the administration of the Company's 76% subsidiary, F1 Modular Limited, as announced on 30 March 2020 and the sale of its interests in Partnering Health Limited and Infracare LIFT Holdings Limited as announced on 7 May 2020.

Despite its best efforts, the Company has been unable to raise further funds with the COVID-19 pandemic seriously restricting the Company's ability to do so.

For the last two months, the Company has been discussing a potential transaction with Piper. The discussions have been wide ranging but have included, amongst other structures, whether Piper could potentially obtain a listing through a Reverse Takeover of the Company pursuant to AIM Rule 14 or another similar transaction (the "Proposed Transaction").

Company Voluntary Arrangement

In order to allow the Company to pursue a future corporate strategy and avoid administration or liquidation and to achieve the best result possible from the current position for creditors, shareholders and other stakeholders, the Board believes that it is in the best interests of the Company to enter into the following arrangements:

· Documentation has been filed in the High Court and will today be dispatched to the creditors of the Company, together with a notice convening a Creditors' Meeting, the purpose of which is to consider the Directors' proposal for a CVA, subject to shareholder approval;

· The Company has engaged Begbies Traynor (Central) LLP to act as Nominee and Supervisor for the CVA;

· Piper Homes plc has paid £50,000 to Ashley House to fund the initial costs of pursuing the proposals, with a further £50,000 payable once the CVA has been approved and the 28 day challenge period has passed; and

· The Company is issuing today a Circular to shareholders ("Circular") setting out the background to the CVA and seeking shareholders' approval for it. Notice convening a General Meeting to be held on 18 August 2020, to consider and, if thought fit, approve a Resolution giving this approval, is set out at the end of the Circular.

The CVA will not result in any distribution being made to existing members in their capacity as shareholders.

Based upon discussions to date, shareholders should be aware that, in any Proposed Transaction, the value attributable to the equity in Ashley House is likely to be minimal, albeit it is anticipated that shareholders would have some further opportunity to participate in the enlarged group through a subscription warrant structure. Further details will be provided in due course.

Any Proposed Transaction with Piper is conditional upon:

(i) the approval of the CVA both by shareholders and by the Company's creditors; and

(ii) the passing in due course at a General Meeting of resolutions to approve the Proposed Transaction, the grant of authority to allot new shares in connection with such transaction and waiver by the Takeover Panel of the mandatory offer requirement which would otherwise arise from such allotment.

If either of the above conditions are not satisfied, then the Proposed Transaction will not proceed and, since the Company would have insufficient working capital to continue to trade, the Directors would likely have no alternative but to place the Company immediately into administration or liquidation. There can be no certainty that the Proposed Transaction will proceed or as to the terms of any Proposed Transaction.

Report and Accounts Update

The Company's reporting deadline for the publication of its annual audited accounts for the period ended 31 October 2019 has been extended to 31 July 2020 as a result of the COVID-19 pandemic. The Company will not now be in a position to publish its accounts by this date. The results for the eighteen month period to 31 October 2019 will show a significant loss.

As stated above, the shares of the Company were suspended from trading on AIM on 6 March 2020 as a result of material financial uncertainty. In order to complete the Proposed Transaction, the Company would need to seek from the London Stock Exchange permission to extend beyond 6 September 2020 the period during which its shares remain suspended and should it do so, such permission may or may not be forthcoming. However, the Company and Piper in any case continue to explore alternative means to deliver a similar commercial outcome and will update shareholders in due course.

The Company again thanks its lenders, creditors, shareholders and all stakeholders for their continued patience and support in this difficult time.

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Not for release, publication or distribution, in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

 

Enquiries:

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

James Hathaway

 

WH Ireland 0207 220 1666

(Nominated Adviser and Broker)

Adrian Hadden

James Sinclair-Ford

Darshan Patel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAFXEDAAEEFA
Date   Source Headline
29th Jun 20189:08 amRNSDirectorate change
10th May 20187:00 amRNSHolding(s) in Company
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
9th May 20187:00 amRNSTrading Update
3rd May 20185:38 pmRNSDirector/PDMR Shareholding
6th Mar 20183:00 pmRNSDirector Dealing
5th Mar 20187:00 amRNSFinancial Close Scarborough Extra Care
1st Mar 20187:00 amRNSAppointment of Finance Director
23rd Feb 201811:54 amRNSHolding(s) in Company
14th Feb 20188:51 amRNSSale of Pharmacy Interest to Repay Debt - Amended
14th Feb 20187:00 amRNSSale of Pharmacy Interest to Repay Debt
2nd Feb 20189:32 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSInterim Results
30th Jan 20184:31 pmRNSDirectors' & PDMRs' Dealings
22nd Dec 20171:07 pmRNSDirector/PDMR Shareholding
15th Dec 20171:56 pmRNSJoint Venture with Morgan Sindall Investments Ltd
24th Nov 20177:00 amRNSUpdate
7th Nov 201711:00 amRNSHolding(s) in Company
31st Oct 20172:28 pmRNSDirectors' & PDMRs' Dealings
26th Oct 20177:00 amRNSUpdate
25th Oct 201712:35 pmRNSResult of AGM
3rd Oct 201710:45 amRNSHolding(s) in Company
3rd Oct 20179:25 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreliminary Results For The Year End 30 April 2017
28th Jul 20174:45 pmRNSDirectors' & PDMRs' Dealings
4th Jul 20174:27 pmRNSDebt Facility from Related Party
28th Apr 20172:20 pmRNSDirectors' & PDMRs' dealings
25th Apr 20173:16 pmRNSDebt Facility from Related Party
27th Mar 201711:09 amRNSDirector Dealing
17th Mar 20173:42 pmRNSDirector Dealing
14th Mar 20171:11 pmRNSAcquisition and Trading Update
22nd Feb 201712:03 pmRNSPosting of Interim Report
30th Jan 20171:27 pmRNSDirectors' & PDMRs' dealings
26th Jan 20177:00 amRNSInterim Report 2016
17th Jan 201710:27 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSReplacement Debt Facility from Related Party
28th Oct 20168:41 amRNSDirectors' & PDMRs' dealings
15th Sep 201610:48 amRNSResult of AGM
23rd Aug 20167:00 amRNSReport and Accounts / AGM
28th Jul 20167:00 amRNSDirectors' & PDMRs' Dealings
13th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:00 amRNSPreliminary results
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 201610:22 amRNSDirectors' & PDMRs' dealings
29th Mar 20167:00 amRNSDirectors & PDMRs dealings
1st Mar 201611:09 amRNSDirector Dealing
10th Feb 20167:00 amRNSAdmission Application Announcement
5th Feb 20165:27 pmRNSPosting of Interim Report
26th Jan 20167:00 amRNSInterim Report 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.